NanoVibronix Inc. secured regulatory approval to commercialize its WoundShield device in Canada.
The device facilitates soft tissue regeneration and wound healing by using ultrasound. It is already approved in Europe and NanoVibronix plans to pursue regulatory approval in the U.S.